Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study


Pivonello R., Petersenn S., Newell-Price J., Findling J. W. , Gu F., Maldonado M., et al.

CLINICAL ENDOCRINOLOGY, cilt.81, ss.408-417, 2014 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 81 Konu: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1111/cen.12431
  • Dergi Adı: CLINICAL ENDOCRINOLOGY
  • Sayfa Sayısı: ss.408-417

Özet

Objective Signs and symptoms of Cushing's disease are associated with high burden of illness. In this analysis, we evaluated the effect of pasireotide treatment on signs and symptoms in patients with Cushing's disease.